Bernard Fourie
- Infectious Diseases top 5%
- Tuberculosis Research and Epidemiology 10
- Molecular Medicine top 10%
- Epidemiology top 10%
- Mycobacterium research and diagnosis 3
- Pneumocystis jirovecii pneumonia detection and treatment 2
- Pneumonia and Respiratory Infections 1
- Pharmaceutical Science top 10%
- Toxicology top 10%
- Bioactive Compounds and Antitumor Agents 1
-
- Infectious Diseases and Tuberculosis 4
- Diagnosis and treatment of tuberculosis 2
-
- Phytochemistry and Bioactive Compounds 1
- Co-authors
- Bjørn BlombergS SpinaciRonald AndersonMoloko C. CholoThuli MthiyaneF A SirgelGeraint DaviesRoxana Rustomjee
- Partner nations
- South AfricaUnited StatesNorway
In The Last Decade
Bernard Fourie
17 papers receiving 685 citations
Peers
Comparison fields: 5 of 91
- Infectious Diseases 453
- Molecular Medicine 52
- Epidemiology 357
- Pharmaceutical Science 48
- Toxicology 23
Countries citing papers authored by Bernard Fourie
This map shows the geographic impact of Bernard Fourie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Fourie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Fourie more than expected).
Fields of papers citing papers by Bernard Fourie
This network shows the impact of papers produced by Bernard Fourie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Fourie. The network helps show where Bernard Fourie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernard Fourie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 4 | |
| 2 | 2019 | 22 | |
| 3 | 2016 | 101 | |
| 4 | 2014 | 16 | |
| 5 | 2013 | 1 | |
| 6 | 2012 | 4 | |
| 7 | 2011 | 8 | |
| 8 | 2011 | 1 | |
| 9 | 2008 | 42 | |
| 10 | A Phase II study of the sterilising activities of ofloxacin, gatifloxacin and moxifloxacin in pulmonary tuberculosis. | 2008 | 230 |
| 11 | 2005 | 40 | |
| 12 | 2004 | 26 | |
| 13 | 2003 | 43 | |
| 14 | The rationale for recommending fixed-dose combination tablets for treatment of tuberculosis. | 2001 | 144 |
| 15 | Trials of anti-tuberculosis treatment as a diagnostic tool in smear-negative tuberculosis are of questionable benefit. | 2000 | 2 |
| 16 | Tuberculosis care in community care organizations in sub-Saharan Africa: practice and potential. | 1997 | 22 |
| 17 | 1992 | 15 |
About Bernard Fourie
Bernard Fourie is a scholar working on Infectious Diseases, Toxicology and Molecular Medicine, having authored 17 papers that have together received 721 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (10 papers), Infectious Diseases and Tuberculosis (4 papers), Mycobacterium research and diagnosis (3 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Diagnosis and treatment of tuberculosis (2 papers), Bioactive Compounds and Antitumor Agents (1 paper), Phytochemistry and Bioactive Compounds (1 paper) and Pneumonia and Respiratory Infections (1 paper). The work is most often cited by research in Infectious Diseases (453 citations), Molecular Medicine (52 citations) and Epidemiology (357 citations). Bernard Fourie has collaborated with scholars based in South Africa, United States and Norway. Frequent co-authors include Bjørn Blomberg, S Spinaci, Ronald Anderson, Moloko C. Cholo, Thuli Mthiyane, F A Sirgel, Geraint Davies, Roxana Rustomjee, D A Mitchison and Christian Lienhardt. Their work appears in journals such as Gastroenterology, Journal of Antimicrobial Chemotherapy and Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.